Peripheral Arterial Disease: New Imaging Agent Study

We are testing a new imaging agent in people with peripheral arterial occlusive disease and healthy volunteers. The goal is to understand its safety and how it distributes in the body.

6-12 monthsSafety phase (I)CardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
University Medical Center Groningen
Department of Surgery / Nuclear Medicine and Molecular Imaging
Groningen, Netherlands
Sponsor: Aplagon Oy
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.